Visitors can explore advanced film capacitors, CalRamic technologies, integrated magnetics, busbars and stator manufacturing capabilities at Hall A6, Booth 419.
At the ESMO Congress in Madrid, NEC Bio presented clinical trial data for NECVAX-NEO1, evaluating oral individualized immunotherapy in neoadjuvant triple-negative breast cancer.
NVIDIA and research institutions introduce RFD4-Proteina and agentic computing workflows to address biological search spaces and adaptive radiation therapy.